StockData
Rockwell Medical, Inc. logo

Rockwell Medical, Inc. (RMTI) income statement

RMTINasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 11/3081% below fair value
$6.26+0.16 (+2.62%)

Close on Nov 19, 2026Market cap $25.23MP/E –Yield –

Rockwell Medical, Inc. income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
17.7%
Operating margin
-6.5%
Net margin
-7.3%
Return on equity, FY2025
-15.3%

Financial strength

Current ratio
3.25
Debt to equity
0.26
Debt to assets
15.9%
Cash to current liabilities
94.1%

Valuation

P/E ratio
–
Price to sales
0.36
Price to book
0.72
Dividend yield
–

See a number that looks wrong?